Mycophenolate mofetil combined with steroids: New experiences in the treatment of idiopathic retroperitoneal fibrosis | Zendy

Katarina Obrenčević | Zendy; Dragan Jovanović | Zendy; Zoran Kovačević | Zendy; R Hrvacević | Zendy; Ljiljana Ignjatović | Zendy; Mirjana Mijušković | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mycophenolate mofetil combined with steroids: New experiences in the treatment of idiopathic retroperitoneal fibrosis

Author(s) -

Katarina Obrenčević,

Dragan Jovanović,

Zoran Kovačević,

R Hrvacević,

Ljiljana Ignjatović,

Mirjana Mijušković

Publication year - 2007

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp0706385o

Subject(s) - medicine , retroperitoneal fibrosis , prednisone , ureterolysis , azathioprine , urology , surgery , hydronephrosis , gastroenterology , fibrosis , disease , urinary system

[corrected] Idiopathic retroperitoneal fibrosis (IRF) is an uncommon disease characterized by a retroperitoneal fibrotic tissue that often involve the ureters, leading to the obstructive nephropathy and variable impairment of renal function. Findings strongly suggest an autoimmune etiology. Surgery, medical treatment with immunosuppressive drugs, or a combination of both are proposed. The optimal treatment has not been established yet. The aim of this study was to present our experience with combined immunosuppressive therapy of IRF, steroids (S) and mycophenolate mofetil (MMF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research